Treatment with casimersen led to a statistically significant increase in dystrophin production in skeletal muscle from baseline to week 48.
Lea Eslava-Kim, PharmD
Lea Eslava-Kim, PharmD, is a Drug Information Specialist for MPR. She received her doctorate in pharmacy from the Ernest Mario School of Pharmacy, Rutgers University and completed her pharmacy residency at Clara Maass Medical Center. She is a licensed pharmacist.